Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Kwality Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
57/99

BSE: 539997 | NSE: Not Listed

NSE BSE
448.55
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  443.00
  •  469.00
  •  442.50
  •  449.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  75
  •  8.11
  •  545.00
  •  248.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 465.42
  • 38.88
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 549.69
  • N/A
  • 2.13

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.77%
  • 3.10%
  • 32.95%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 9.18%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.46
  • 8.59
  • -1.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 32.91
  • 31.05
  • 16.04

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 35.05
  • 20.70
  • 8.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.48
  • 16.13
  • 22.29

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.80
  • 4.61
  • 5.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.68
  • 9.39
  • 10.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
78.09
56.20
38.95%
69.65
55.80
24.82%
67.45
70.22
-3.94%
68.80
64.05
7.42%
Expenses
61.41
41.10
49.42%
54.42
40.25
35.20%
53.68
52.21
2.82%
57.32
47.83
19.84%
EBITDA
16.68
15.10
10.46%
15.23
15.55
-2.06%
13.77
18.01
-23.54%
11.48
16.22
-29.22%
EBIDTM
21.36%
26.86%
21.87%
27.87%
20.42%
25.64%
16.69%
25.33%
Other Income
0.62
0.35
77.14%
0.23
1.13
-79.65%
0.40
0.38
5.26%
1.46
1.60
-8.75%
Interest
2.73
1.95
40.00%
2.41
1.18
104.24%
2.19
1.22
79.51%
1.67
1.03
62.14%
Depreciation
4.82
3.55
35.77%
4.88
3.84
27.08%
4.79
3.14
52.55%
4.43
2.76
60.51%
PBT
9.75
9.95
-2.01%
8.17
11.66
-29.93%
7.20
14.02
-48.64%
-9.68
14.04
-
Tax
2.07
2.80
-26.07%
1.95
2.27
-14.10%
1.79
3.50
-48.86%
-2.28
3.55
-
PAT
7.68
7.14
7.56%
6.22
9.39
-33.76%
5.40
10.52
-48.67%
-7.40
10.49
-
PATM
9.83%
12.71%
8.92%
16.83%
8.01%
14.98%
-10.76%
16.38%
EPS
7.41
6.84
8.33%
6.01
9.08
-33.81%
5.23
10.15
-48.47%
-7.11
10.12
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
283.99
251.03
456.19
262.01
139.30
166.29
137.49
98.32
74.17
52.38
59.60
Net Sales Growth
15.32%
-44.97%
74.11%
88.09%
-16.23%
20.95%
39.84%
32.56%
41.60%
-12.11%
 
Cost Of Goods Sold
141.82
69.44
141.83
165.59
87.08
119.44
101.59
71.29
56.77
38.67
46.17
Gross Profit
142.17
181.59
314.36
96.42
52.22
46.85
35.91
27.03
17.40
13.71
13.42
GP Margin
50.06%
72.34%
68.91%
36.80%
37.49%
28.17%
26.12%
27.49%
23.46%
26.17%
22.52%
Total Expenditure
226.83
190.30
284.52
233.15
125.08
150.58
125.81
89.41
69.15
49.11
56.07
Power & Fuel Cost
-
12.98
11.07
6.13
4.20
3.71
2.71
2.81
2.31
1.80
0.00
% Of Sales
-
5.17%
2.43%
2.34%
3.02%
2.23%
1.97%
2.86%
3.11%
3.44%
0%
Employee Cost
-
28.16
18.80
14.70
10.92
7.74
4.89
3.60
2.16
1.60
1.79
% Of Sales
-
11.22%
4.12%
5.61%
7.84%
4.65%
3.56%
3.66%
2.91%
3.05%
3.00%
Manufacturing Exp.
-
50.12
68.37
6.87
3.54
2.87
5.16
2.64
1.41
1.28
0.00
% Of Sales
-
19.97%
14.99%
2.62%
2.54%
1.73%
3.75%
2.69%
1.90%
2.44%
0%
General & Admin Exp.
-
16.11
9.10
12.80
8.46
5.83
3.18
2.58
2.77
1.36
8.10
% Of Sales
-
6.42%
1.99%
4.89%
6.07%
3.51%
2.31%
2.62%
3.73%
2.60%
13.59%
Selling & Distn. Exp.
-
12.66
35.13
26.09
10.60
10.79
8.06
5.04
3.29
4.06
0.00
% Of Sales
-
5.04%
7.70%
9.96%
7.61%
6.49%
5.86%
5.13%
4.44%
7.75%
0%
Miscellaneous Exp.
-
0.83
0.23
0.97
0.28
0.19
0.23
1.46
0.44
0.35
0.00
% Of Sales
-
0.33%
0.05%
0.37%
0.20%
0.11%
0.17%
1.48%
0.59%
0.67%
0%
EBITDA
57.16
60.73
171.67
28.86
14.22
15.71
11.68
8.91
5.02
3.27
3.53
EBITDA Margin
20.13%
24.19%
37.63%
11.01%
10.21%
9.45%
8.50%
9.06%
6.77%
6.24%
5.92%
Other Income
2.71
2.94
3.51
1.59
3.66
0.61
0.80
1.21
0.36
0.42
0.14
Interest
9.00
6.61
2.92
2.68
2.52
2.29
2.21
1.95
1.22
1.04
0.72
Depreciation
18.92
14.96
10.69
6.49
4.43
3.12
2.98
2.51
1.69
1.30
1.20
PBT
15.44
42.10
161.57
21.27
10.92
10.91
7.30
5.65
2.48
1.35
1.75
Tax
3.53
6.29
41.63
6.38
2.71
3.35
2.87
2.37
1.19
0.55
0.81
Tax Rate
22.86%
24.60%
25.77%
30.00%
24.82%
30.71%
39.32%
41.95%
47.98%
40.74%
46.29%
PAT
11.90
19.37
119.99
15.15
8.32
7.56
4.54
3.37
1.55
0.91
0.96
PAT before Minority Interest
11.97
19.28
119.94
14.89
8.21
7.56
4.42
3.28
1.28
0.80
0.93
Minority Interest
0.07
0.09
0.05
0.26
0.11
0.00
0.12
0.09
0.27
0.11
0.03
PAT Margin
4.19%
7.72%
26.30%
5.78%
5.97%
4.55%
3.30%
3.43%
2.09%
1.74%
1.61%
PAT Growth
-68.30%
-83.86%
692.01%
82.09%
10.05%
66.52%
34.72%
117.42%
70.33%
-5.21%
 
EPS
11.44
18.63
115.38
14.57
8.00
7.27
4.37
3.24
1.49
0.88
0.92

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
200.52
181.14
61.15
46.01
37.30
29.75
25.58
21.34
19.08
17.78
Share Capital
10.38
10.38
10.38
10.38
10.38
10.38
5.19
5.01
4.41
4.41
Total Reserves
190.14
170.77
50.78
35.63
26.92
19.37
20.40
16.75
14.81
13.37
Non-Current Liabilities
28.62
21.32
28.08
19.78
8.23
5.47
4.24
3.32
0.83
2.10
Secured Loans
27.19
19.59
16.26
8.18
7.01
3.11
2.63
2.35
0.30
0.54
Unsecured Loans
0.12
0.70
2.00
2.00
0.58
1.59
0.67
0.35
0.50
0.87
Long Term Provisions
0.90
0.75
0.68
0.62
0.52
0.55
0.54
0.17
0.00
0.10
Current Liabilities
125.95
139.49
78.29
67.75
60.83
61.98
41.60
26.54
17.41
15.27
Trade Payables
35.19
34.51
26.21
22.97
17.07
22.14
12.74
9.67
4.19
7.31
Other Current Liabilities
33.31
40.97
29.82
20.55
21.73
15.91
11.46
5.94
6.02
3.84
Short Term Borrowings
50.96
23.00
16.45
21.24
18.73
21.33
15.09
9.65
6.63
4.10
Short Term Provisions
6.48
41.00
5.80
3.00
3.30
2.60
2.30
1.28
0.58
0.02
Total Liabilities
353.64
340.60
166.22
132.50
105.38
96.21
70.92
51.20
37.32
35.12
Net Block
120.50
91.73
56.53
42.69
29.08
20.38
17.01
12.72
12.74
12.64
Gross Block
170.15
128.13
82.22
62.60
47.64
35.82
29.58
22.78
23.11
21.37
Accumulated Depreciation
49.65
36.39
25.69
19.91
18.56
15.44
12.56
10.06
10.37
8.73
Non Current Assets
146.43
112.77
60.33
43.46
29.99
21.14
17.75
12.88
12.86
12.78
Capital Work in Progress
14.29
12.15
2.89
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.73
0.65
0.79
0.63
0.62
0.03
0.03
0.14
Long Term Loans & Adv.
10.71
8.11
0.17
0.12
0.12
0.12
0.12
0.12
0.10
0.00
Other Non Current Assets
0.93
0.78
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
207.20
227.82
105.90
89.03
75.35
75.00
53.07
38.19
24.46
22.34
Current Investments
0.00
0.00
4.44
3.34
4.04
4.71
3.03
1.91
0.97
0.50
Inventories
86.31
53.36
17.36
22.42
11.25
15.03
13.85
10.35
6.46
7.35
Sundry Debtors
71.69
69.13
35.71
30.33
38.43
37.03
22.61
18.03
9.05
6.75
Cash & Bank
7.36
12.95
5.81
1.54
1.40
1.61
2.99
1.35
1.03
0.90
Other Current Assets
41.83
0.00
0.09
0.12
20.24
16.61
10.58
6.56
6.94
6.84
Short Term Loans & Adv.
41.83
92.38
42.49
31.29
20.18
16.49
10.53
6.50
6.91
6.77
Net Current Assets
81.25
88.33
27.61
21.28
14.52
13.02
11.47
11.65
7.05
7.08
Total Assets
353.63
340.59
166.23
132.49
105.37
96.21
70.92
51.21
37.32
35.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
41.38
60.60
26.71
6.16
13.58
-0.57
4.30
-2.85
PBT
25.57
161.57
21.27
10.92
10.91
7.30
5.65
2.48
Adjustment
20.95
13.56
9.09
7.09
5.22
4.36
4.69
3.25
Changes in Working Capital
1.01
-73.18
2.72
-9.13
0.89
-9.17
-3.62
-7.31
Cash after chg. in Working capital
47.54
101.95
33.09
8.87
17.02
2.49
6.72
-1.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.16
-41.35
-6.38
-2.71
-3.44
-3.06
-2.42
-1.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-48.44
-62.93
-23.20
-17.80
-11.78
-6.20
-7.26
-2.47
Net Fixed Assets
-44.16
-55.17
-22.50
-14.92
-11.81
-6.25
-6.79
Net Investments
0.00
5.17
-1.18
0.92
0.08
-1.87
-1.99
Others
-4.28
-12.93
0.48
-3.80
-0.05
1.92
1.52
Cash from Financing Activity
0.99
5.66
0.77
11.77
-2.00
5.39
4.60
5.63
Net Cash Inflow / Outflow
-6.07
3.33
4.27
0.14
-0.21
-1.38
1.65
0.31
Opening Cash & Equivalents
9.13
5.81
1.54
1.40
1.61
2.99
1.35
1.03
Closing Cash & Equivalent
3.07
9.13
5.81
1.54
1.40
1.61
2.99
1.35

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
192.48
173.81
58.16
43.57
35.14
27.83
23.79
20.78
20.89
20.16
ROA
5.55%
47.33%
9.97%
6.90%
7.50%
5.29%
5.37%
2.90%
2.21%
2.66%
ROE
10.15%
99.66%
28.21%
20.10%
23.13%
16.51%
14.41%
6.54%
4.43%
5.26%
ROCE
12.27%
95.32%
26.36%
18.49%
21.91%
19.19%
19.74%
12.45%
9.61%
10.52%
Fixed Asset Turnover
1.68
4.34
3.62
2.53
3.98
4.20
3.76
3.23
2.35
2.79
Receivable days
102.38
41.94
46.00
90.08
82.82
79.17
75.44
66.62
55.06
41.36
Inventory Days
101.54
28.29
27.71
44.10
28.84
38.34
44.92
41.35
48.10
44.99
Payable days
183.20
78.14
54.20
56.97
49.86
49.48
45.68
36.66
43.53
54.27
Cash Conversion Cycle
20.73
-7.91
19.51
77.22
61.80
68.03
74.67
71.31
59.64
32.09
Total Debt/Equity
0.45
0.35
0.68
0.77
0.79
0.92
0.77
0.62
0.43
0.32
Interest Cover
4.87
56.38
8.93
5.32
5.76
4.31
3.89
3.02
2.30
3.41

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Kwality Pharma - Quarterly Results
    6th Feb 2024, 19:40 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.